177 related articles for article (PubMed ID: 28357633)
21. Surgery of primary lung cancer with oligometastatic m1b synchronous single brain metastasis: analysis of 37 cases.
Cheufou DH; Welter S; Chalvatzoulis E; Christof D; Theegarten D; Stamatis G
Thorac Cardiovasc Surg; 2014 Oct; 62(7):612-5. PubMed ID: 25136943
[TBL] [Abstract][Full Text] [Related]
22. Can upfront systemic chemotherapy replace stereotactic radiosurgery or whole brain radiotherapy in the treatment of non-small cell lung cancer patients with asymptomatic brain metastases?
Kim KH; Lee J; Lee JI; Nam DH; Kong DS; Ahn YC; Park HC; Kwon OJ; Kim H; Chang MH; Yi SY; Ji SH; Park YH; Ahn JS; Park K; Ahn MJ
Lung Cancer; 2010 May; 68(2):258-63. PubMed ID: 19592127
[TBL] [Abstract][Full Text] [Related]
23. Combined treatment of non-small cell lung cancer with synchronous brain metastases: a single center experience.
Melloni G; Bandiera A; Gregorc V; Carretta A; Ciriaco P; Viganò M; Franzin A; Bolognesi A; Picozzi P; Zannini P
J Cardiovasc Surg (Torino); 2011 Aug; 52(4):613-9. PubMed ID: 21792167
[TBL] [Abstract][Full Text] [Related]
24. Validation study of the proposed IASLC staging revisions of the T4 and M non-small cell lung cancer descriptors using data from 23,583 patients in the California Cancer Registry.
Ou SH; Zell JA
J Thorac Oncol; 2008 Mar; 3(3):216-27. PubMed ID: 18317063
[TBL] [Abstract][Full Text] [Related]
25. Cost-effectiveness of stereotactic radiosurgery with and without whole-brain radiotherapy for the treatment of newly diagnosed brain metastases.
Hall MD; McGee JL; McGee MC; Hall KA; Neils DM; Klopfenstein JD; Elwood PW
J Neurosurg; 2014 Dec; 121 Suppl():84-90. PubMed ID: 25434941
[TBL] [Abstract][Full Text] [Related]
26. Prognostic factors in nonsmall cell lung cancer: insights from the German CRISP registry.
Metzenmacher M; Griesinger F; Hummel HD; Elender C; Schäfer H; de Wit M; Kaiser U; Kern J; Jänicke M; Spring L; Zacharias S; Kaiser-Osterhues A; Groth A; Hipper A; Zaun G; Dörfel S; Güldenzoph B; Müller L; Uhlig J; Thomas M; Sebastian M; Eberhardt WEE;
Eur Respir J; 2023 Feb; 61(2):. PubMed ID: 36180086
[TBL] [Abstract][Full Text] [Related]
27. Surgical treatment of primary lung cancer with synchronous brain metastases.
Billing PS; Miller DL; Allen MS; Deschamps C; Trastek VF; Pairolero PC
J Thorac Cardiovasc Surg; 2001 Sep; 122(3):548-53. PubMed ID: 11547308
[TBL] [Abstract][Full Text] [Related]
28. Skin rash and bronchoalveolar histology correlates with clinical benefit in patients treated with gefitinib as a therapy for previously treated advanced or metastatic non-small cell lung cancer.
Dudek AZ; Kmak KL; Koopmeiners J; Keshtgarpour M
Lung Cancer; 2006 Jan; 51(1):89-96. PubMed ID: 16290256
[TBL] [Abstract][Full Text] [Related]
29. Increased survival with the combination of stereotactic radiosurgery and gefitinib for non-small cell lung cancer brain metastasis patients: a nationwide study in Taiwan.
Lin CH; Hsu KH; Chang SN; Tsou HK; Sheehan J; Sheu ML; Pan HC
Radiat Oncol; 2015 Jun; 10():127. PubMed ID: 26048754
[TBL] [Abstract][Full Text] [Related]
30. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
[TBL] [Abstract][Full Text] [Related]
31. The effect of non-small cell lung cancer histology on survival as measured by the graded prognostic assessment in patients with brain metastases treated by hypofractionated stereotactic radiotherapy.
Ma LH; Li G; Zhang HW; Wang ZY; Dang J; Zhang S; Yao L
Radiat Oncol; 2016 Jul; 11():92. PubMed ID: 27411944
[TBL] [Abstract][Full Text] [Related]
32. Stereotactic body radiotherapy for centrally located early-stage non-small cell lung cancer or lung metastases from the RSSearch(®) patient registry.
Davis JN; Medbery C; Sharma S; Pablo J; Kimsey F; Perry D; Muacevic A; Mahadevan A
Radiat Oncol; 2015 May; 10():113. PubMed ID: 25975848
[TBL] [Abstract][Full Text] [Related]
33. Long-term outcomes in radically treated synchronous vs. metachronous oligometastatic non-small-cell lung cancer.
Fleckenstein J; Petroff A; Schäfers HJ; Wehler T; Schöpe J; Rübe C
BMC Cancer; 2016 Jun; 16():348. PubMed ID: 27255302
[TBL] [Abstract][Full Text] [Related]
34. Hypofractionated stereotactic radiotherapy with or without whole-brain radiotherapy for patients with newly diagnosed brain metastases from non-small cell lung cancer.
Ma LH; Li G; Zhang HW; Wang ZY; Dang J; Zhang S; Yao L; Zhang XM
J Neurosurg; 2012 Dec; 117 Suppl():49-56. PubMed ID: 23205789
[TBL] [Abstract][Full Text] [Related]
35. Non-small cell lung cancer with ipsilateral pulmonary metastases: prognosis analysis and staging assessment.
Lee JG; Lee CY; Kim DJ; Chung KY; Park IK
Eur J Cardiothorac Surg; 2008 Mar; 33(3):480-4. PubMed ID: 18249000
[TBL] [Abstract][Full Text] [Related]
36. Operation and Chemotherapy: Prognostic Factors for Lung Cancer With One Synchronous Metastasis.
Toffart AC; Duruisseaux M; Brichon PY; Pirvu A; Villa J; Selek L; Guillem P; Dumas I; Ferrer L; Levra MG; Moro-Sibilot D
Ann Thorac Surg; 2018 Mar; 105(3):957-965. PubMed ID: 29397931
[TBL] [Abstract][Full Text] [Related]
37. Radical treatment of synchronous oligometastatic non-small cell lung carcinoma (NSCLC): patient outcomes and prognostic factors.
Griffioen GH; Toguri D; Dahele M; Warner A; de Haan PF; Rodrigues GB; Slotman BJ; Yaremko BP; Senan S; Palma DA
Lung Cancer; 2013 Oct; 82(1):95-102. PubMed ID: 23973202
[TBL] [Abstract][Full Text] [Related]
38. Gamma knife radiosurgery for the management of cerebral metastases from non-small cell lung cancer.
Bowden G; Kano H; Caparosa E; Park SH; Niranjan A; Flickinger J; Lunsford LD
J Neurosurg; 2015 Apr; 122(4):766-72. PubMed ID: 25658792
[TBL] [Abstract][Full Text] [Related]
39. The impact of superior mediastinal lymph node metastases on prognosis in non-small cell lung cancer located in the right middle lobe.
Sakao Y; Okumura S; Mingyon M; Uehara H; Ishikawa Y; Nakagawa K
J Thorac Oncol; 2011 Mar; 6(3):494-9. PubMed ID: 21266920
[TBL] [Abstract][Full Text] [Related]
40. [The pathological characteristics and outcomes of 40 surgically treated stage M1b non-small cell lung cancer patients].
Pan Y; Wang YL; Wang YG; Wang DL
Zhonghua Zhong Liu Za Zhi; 2019 Jan; 41(1):63-67. PubMed ID: 30678419
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
